OpenVSafe by OpenVAERS
Search V-safe

6JL-65255-22058

2 vaccinations 6 coded responses 15 check-ins 6 free-text entries 3 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
104 / NY
Registered
2020-12-30
Relationship
Self
Race
Other
Ethnicity
Hispanic or Latino

Timeline

  1. 2020-12-30
    Registered in v-safe
  2. 2020-12-30
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-30
    Survey response — day 0, dose 1
    MedDRA: Dizziness — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Free text: Lightheadedness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-31
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Good · Site: Pain · Headache
    Free text: Lightheadedness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Good
    Free text: Lightheadedness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-15
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-22
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  11. 2021-01-29
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-02-07
    Health check-in — day 14, dose 2
    Feeling: Poor
    Adult check-in
  13. 2021-02-12
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-21
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-26
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-05
    Survey response — day 42, dose 2
    MedDRA: Hyperthyroidism — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Never had problems with thyroid before; now diagnosed with subclinical hyperthyroidism (low TSH).
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-05
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-04-25
    Survey response — 3 months, dose 2
    MedDRA: Abdominal pain, Condition aggravated, Polyarthritis, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Migratory polyarthritis involving hips, ankles, wrists, and fingersAbdominal pain, worsening acid refluxPlan is to see doctor beginning of May
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-04-25
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-07-26
    Survey response — 6 months, dose 2
    MedDRA: Antinuclear antibody positive, Arthralgia, Hyperthyroidism, Sjogren's syndrome — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Polyarticular migratory joint pains - found to be SSA positive and diagnosed with Sjogren syndrome. Additionally had subclinical hyperthyroidism which resolved.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  21. 2021-07-26
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-07-29

Vaccinations

DoseDateManufacturerCo-administered
12020-12-30Pfizer-BioNTech
22021-01-22Pfizer-BioNTech

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-30

Systemic reaction (other): Lightheadedness

Release 1 — days 1–6 daily, dose 1

2020-12-31

Systemic reaction (other): Lightheadedness

2021-01-04

Systemic reaction (other): Lightheadedness

Release 5 — day 42, dose 2

2021-03-05

Symptoms: Never had problems with thyroid before; now diagnosed with subclinical hyperthyroidism (low TSH).

Release 7 — 3 months, dose 2

2021-04-25

Symptoms: Migratory polyarthritis involving hips, ankles, wrists, and fingersAbdominal pain, worsening acid refluxPlan is to see doctor beginning of May

Release 9 — 6 months, dose 2

2021-07-26

Symptoms: Polyarticular migratory joint pains - found to be SSA positive and diagnosed with Sjogren syndrome. Additionally had subclinical hyperthyroidism which resolved.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain · · ✓
SDAntinuclear antibody positive ✓ · ✓
SDArthralgia ✓ · ✓
SDCondition aggravated · · ✓
SDHyperthyroidism ✓ ✓ ✓
SDPolyarthritis · · ✓
SDPre-existing disease ✓ ✓ ✓
SDSjogren's syndrome ✓ · ✓
SRODizziness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release